T cell-depleted nonmyeloablative stem cell transplantation: what is the optimum balance between the intensity of host conditioning and the degree of T cell depletion of the graft?

被引:9
作者
Chakrabarti, S [1 ]
McDonald, D
Milligan, DW
机构
[1] Birmingham Heartlands Hosp, Dept Haematol, Birmingham B9 5SS, W Midlands, England
[2] Blood Transfus Serv, Stem Cell Grp, Birmingham, W Midlands, England
关键词
D O I
10.1038/sj.bmt.1703117
中图分类号
Q6 [生物物理学];
学科分类号
071011 ;
摘要
引用
收藏
页码:313 / 314
页数:2
相关论文
共 6 条
[1]  
Chakrabarti S, 2000, BLOOD, V96, p586A
[2]  
Craddock C, 2000, BRIT J HAEMATOL, V111, P797
[3]   Melphalan and purine analog-containing preparative regimens: reduced-intensity conditioning for patients with hematologic malignancies undergoing allogeneic progenitor cell transplantation [J].
Giralt, S ;
Thall, PF ;
Khouri, I ;
Wang, XM ;
Braunschweig, I ;
Ippolitti, C ;
Claxton, D ;
Donato, M ;
Bruton, J ;
Cohen, A ;
Davis, M ;
Andersson, BS ;
Anderlini, P ;
Gajewski, J ;
Kornblau, S ;
Andreeff, M ;
Przepiorka, D ;
Ueno, NT ;
Molldrem, J ;
Champlin, R .
BLOOD, 2001, 97 (03) :631-637
[4]   CD52 antibodies for prevention of graft-versus-host disease and graft rejection following transplantation of allogeneic peripheral blood stem cells [J].
Hale, G ;
Jacobs, P ;
Wood, L ;
Fibbe, WE ;
Barge, R ;
Novitzky, N ;
du Toit, C ;
Abrahams, L ;
Thomas, V ;
Bunjes, D ;
Duncker, C ;
Wiesneth, M ;
Selleslag, D ;
Hidajat, M ;
Starobinski, M ;
Bird, P ;
Waldmann, H .
BONE MARROW TRANSPLANTATION, 2000, 26 (01) :69-76
[5]  
Kottaridis PD, 2000, BLOOD, V96, P2419
[6]   Nonmyeloablative stem cell transplantation and cell therapy as an alternative to conventional bone marrow transplantation with lethal cytoreduction for the treatment of malignant and nonmalignant hematologic diseases [J].
Slavin, S ;
Nagler, A ;
Naparstek, E ;
Kapelushnik, Y ;
Aker, M ;
Cividalli, G ;
Varadi, G ;
Kirschbaum, M ;
Ackerstein, A ;
Samuel, S ;
Amar, A ;
Brautbar, C ;
Ben-Tal, O ;
Eldor, A ;
Or, R .
BLOOD, 1998, 91 (03) :756-763